Target intelligence / Profile preview

Ribosomal protein L36a pseudogene 35 (RPL36AP35)

Target
RPL36AP35
Molecular classification
Other (Pseudogene)
01

Overview

RPL36AP35 is a pseudogene that shares sequence similarity with the gene encoding ribosomal protein L36a (RPL36A)[5][6][8][12]. Pseudogenes are genomic DNA sequences similar to known genes but are generally nonfunctional products of gene duplication or retrotransposition. RPL36AP35, like other processed pseudogenes, does not encode a functional protein and thus is not considered a therapeutic target such as a receptor, enzyme, transporter, or transcription factor. It is simply one of many RPL36A-related pseudogenes dispersed throughout the human genome. There are no known biological functions, disease roles, interacting drugs, mechanisms of action, biomarker utility, or safety concerns directly attributable to RPL36AP35[5][6][8][12]. Its primary relevance is as part of the genomic record, and not as a functional molecule in cell biology or therapeutics. Notes regarding target integrity: - This is a pseudogene, not a protein-coding gene. - It does not encode a functional ribosomal protein. - It is not considered a valid therapeutic target and should not be used for drug discovery or biomarker research. - Querying this pseudogene for roles in disease, as a therapeutic target, or drug interactions is technically incorrect[5][6][8][12].

Other names
RPL36A_16_1006RPL36AP35

Beyond the preview

Go deeper on Ribosomal protein L36a pseudogene 35 (RPL36AP35).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L36a pseudogene 35 (RPL36AP35).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call